Protalix BioTherapeutics, Inc. (PLX)
NYSEAMERICAN: PLX · Real-Time Price · USD
3.030
-0.020 (-0.66%)
Nov 16, 2026, 4:00 PM EST - Market closed

Protalix BioTherapeutics Balance Sheet

Millions USD. Fiscal year is Jan - Dec.

Assets

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
22.0414.6819.7623.6317.1138.99
Short-Term Investments
26.515.5915.0720.935.07-
Cash & Short-Term Investments
48.5430.2734.8344.5622.1838.99
Cash Growth
65.26%-13.08%-21.84%100.90%-43.11%1.14%
Accounts Receivable
13.918.842.915.274.593.44
Other Receivables
-0.630.490.480.360.31
Receivables
13.919.473.45.754.953.75
Inventory
34.325.7321.2419.0516.817.95
Prepaid Expenses
-0.390.50.440.770.91
Other Current Assets
2.120.80.110.130.170.07
Total Current Assets
98.8766.6760.0869.9344.8861.67
Property, Plant & Equipment
14.0412.5810.0210.889.649.92
Long-Term Deferred Tax Assets
2.32.522.863.09--
Other Long-Term Assets
3.030.580.460.531.272.08
Total Assets
118.2482.3573.4284.4355.7973.67

Liabilities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Accounts Payable
4.785.264.534.325.866.99
Accrued Expenses
17.414.5313.813.211.616.34
Current Portion of Long-Term Debt
---20.25--
Current Portion of Leases
1.691.381.51.411.121.21
Current Income Taxes Payable
2.942.953.482.880.53-
Current Unearned Revenue
----13.188.55
Other Current Liabilities
3.432.42.313.480.140.1
Total Current Liabilities
30.2326.5225.6245.5332.4333.18
Long-Term Debt
----28.1927.89
Long-Term Leases
7.466.944.034.624.174.38
Long-Term Unearned Revenue
-----11.79
Pension & Post-Retirement Benefits
-0.660.560.711.642.47
Total Liabilities
37.6934.1230.2150.8766.4379.7

Shareholders' Equity

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Common Stock
0.080.080.080.070.050.05
Additional Paid-In Capital
439.41433.15421.53415.05379.17368.85
Retained Earnings
-358.94-385-378.39-381.55-389.86-374.93
Shareholders' Equity
80.5548.2343.2133.57-10.64-6.04
Total Liabilities & Equity
118.2482.3573.4284.4355.7973.67

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Total Debt
9.158.325.5326.2833.4733.47
Net Cash (Debt)
39.3921.9529.318.28-11.295.52
Net Cash Growth
85.88%-25.09%60.31%---
Net Cash Per Share
0.480.280.360.22-0.230.12
Filing Date Shares Outstanding
84.3280.5778.0373.0557.3546.32
Total Common Shares Outstanding
82.4980.4375.8572.9553.7945.56
Working Capital
68.6440.1634.4624.412.4528.49
Book Value Per Share
0.980.600.570.46-0.20-0.13
Tangible Book Value
80.5548.2343.2133.57-10.64-6.04
Tangible Book Value Per Share
0.980.600.570.46-0.20-0.13
Machinery
-23.8622.4222.0221.3220.96
Leasehold Improvements
-18.0717.9117.6416.9216.76
SEC Filings: 10-K · 10-Q